Literature DB >> 9140385

beta-Catenin--one player, two games.

E Resnik.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9140385     DOI: 10.1038/ng0597-9

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  5 in total

1.  Beta-catenin, an inducer of uncontrolled cell proliferation and migration in malignancies, is localized in the cytoplasm of vascular endothelium during neovascularization after myocardial infarction.

Authors:  W M Blankesteijn; M E van Gijn; Y P Essers-Janssen; M J Daemen; J F Smits
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

2.  Prognostic significance of survivin, β-catenin and p53 expression in urothelial carcinoma.

Authors:  Serkan Senol; Asif Yildirim; Bahar Ceyran; Fatih Uruc; Ebru Zemheri; Seyma Ozkanli; Ibrahim Akalin; Ismail Ulus; Turhan Caskurlu; Abdullah Aydin
Journal:  Bosn J Basic Med Sci       Date:  2015-08-19       Impact factor: 3.363

3.  Molecular analysis of the beta-catenin gene in patients with the Mayer-Rokitansky-Küster-Hauser syndrome.

Authors:  Juliana B Drummond; Camila F Rezende; Fabio C Peixoto; Joana S Carvalho; Fernando M Reis; Luiz De Marco
Journal:  J Assist Reprod Genet       Date:  2008-11-01       Impact factor: 3.412

4.  Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression.

Authors:  L B Koppert; A W van der Velden; M van de Wetering; M Abbou; A M W van den Ouweland; H W Tilanus; B P L Wijnhoven; W N M Dinjens
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

5.  Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription.

Authors:  Jaime G Fernández; Diego A Rodríguez; Manuel Valenzuela; Claudia Calderon; Ulises Urzúa; David Munroe; Carlos Rosas; David Lemus; Natalia Díaz; Mathew C Wright; Lisette Leyton; Julio C Tapia; Andrew Fg Quest
Journal:  Mol Cancer       Date:  2014-09-09       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.